IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against GNC Holdings Inc. and Encourages Investors to Contact the Firm before the Deadline

IRVINE, Calif.--(BUSINESS WIRE)-- Khang & Khang LLP (the “Firm”) announces that a class action lawsuit has been filed against GNC Holdings Inc. (“GNC” or the “Company”) (NYSE: GNC). Investors who purchased or otherwise acquired shares between November 28, 2011 and October 28, 2015, inclusive (the “Class Period”) are encouraged to contact the Firm prior to the December 28, 2015 lead plaintiff motion deadline.

If you purchased shares of GNC during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at [email protected].

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the complaint, on October 22, 2015, the State of Oregon initiated a lawsuit against GNC claiming that the Company’s nutritional and dietary supplements are laced with unapproved drugs, including picamilon, a Russian prescription medicine for neurological conditions, and BMPEA, which was first synthesized in the 1930s as a replacement for amphetamines and never studied in humans. When the truth was revealed, shares dropped causing investors harm.

If you purchased shares of GNC during the Class Period, you have until December 28, 2015 to ask the Court to appoint you as lead plaintiff. If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by email at [email protected].

This press release may constitute Attorney Advertising in some jurisdictions.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151201006951/en/

KHANG & KHANG LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
[email protected]

Source: Khang & Khang LLP

You May Also Be Interested In

• ROSEN, A LEADING NATIONAL FIRM, Encourages Sharecare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SHCR
• CoTec Holdings Corp. Announces Initial Closing of Non-Brokered Private Placement
• ADSK INVESTOR ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Autodesk, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADSK